TY  - GEN
AU  - Michielsens,Celia A J
AU  - Boers,Nadine
AU  - den Broeder,Nathan
AU  - Wenink,Mark H
AU  - van der Maas,Aatke
AU  - Mahler,Elien A M
AU  - Mulder,Michelle L M
AU  - van der Heijde,Désirée
AU  - van den Hoogen,Frank H J
AU  - Verhoef,Lise M
AU  - den Broeder,Alfons A
TI  - Dose reduction and withdrawal strategy for TNF-inhibitors in psoriatic arthritis and axial spondyloarthritis: design of a pragmatic open-label, randomised, non-inferiority trial
SN  - 1745-6215
PY  - 2020///1118
KW  - Adalimumab
KW  - adverse effects
KW  - Adolescent
KW  - Adult
KW  - Antibodies, Monoclonal
KW  - Arthritis, Psoriatic
KW  - drug therapy
KW  - Bayes Theorem
KW  - Case-Control Studies
KW  - Cost-Benefit Analysis
KW  - Dose-Response Relationship, Drug
KW  - Etanercept
KW  - Follow-Up Studies
KW  - Humans
KW  - Infliximab
KW  - Netherlands
KW  - epidemiology
KW  - Quality of Life
KW  - Research Design
KW  - Severity of Illness Index
KW  - Spondylarthritis
KW  - Tumor Necrosis Factor Inhibitors
KW  - Young Adult
N1  - Publication Type: Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1186/s13063-019-4000-5
ER  -